Barclay Buck A. Phillips

2018

In 2018, Barclay Buck A. Phillips earned a total compensation of $714.9K as Chief Financial Officer and Senior Vice President, Corporate Development at G1 Therapeutics, a 79% decrease compared to previous year.

Compensation breakdown

Bonus$120,000
Non-Equity Incentive Plan$156,695
Salary$370,000
Other$68,185
Total$714,880

Phillips received $370K in salary, accounting for 52% of the total pay in 2018.

Phillips also received $120K in bonus, $156.7K in non-equity incentive plan and $68.2K in other compensation.

Rankings

In 2018, Barclay Buck A. Phillips' compensation ranked 10,627th out of 14,244 executives tracked by ExecPay. In other words, Phillips earned more than 25.4% of executives.

ClassificationRankingPercentile
All
10,627
out of 14,244
25th
Division
Manufacturing
4,283
out of 5,765
26th
Major group
Chemicals And Allied Products
1,615
out of 2,128
24th
Industry group
Drugs
1,364
out of 1,817
25th
Industry
Pharmaceutical Preparations
1,049
out of 1,391
25th
Source: SEC filing on April 30, 2019.

Phillips' colleagues

We found five more compensation records of executives who worked with Barclay Buck A. Phillips at G1 Therapeutics in 2018.

2018

John Demaree

G1 Therapeutics

Chief Commercial Officer

2018

James Hanson

G1 Therapeutics

General Counsel

2018

Terry Murdock

G1 Therapeutics

Chief Operating Officer

2018

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2018

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

News

You may also like